XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Oct. 04, 2025
Sep. 28, 2024
Operating Activities    
Net loss $ (62,223) $ (167,187)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation of property and equipment 18,769 19,302
Amortization of other intangible assets 11,074 17,596
Stock-based compensation expense 59,645 45,358
Deferred income taxes 2,026 29,100
Changes in operating assets and liabilities:    
Accounts receivable (12,829) (19,585)
Inventories 23,316 54,724
Prepaid expenses and other assets 9,080 23,091
Accounts payable 11,141 (13,849)
Other current liabilities and income taxes 29,901 (5,004)
Deferred revenue and returns liability 5,374 6,361
Other non-current liabilities (7,916) (13,946)
Net cash provided by (used in) operating activities 87,358 (24,039)
Investing Activities    
Purchases of marketable securities (34,790) (28,363)
Sales of marketable securities 15,332 44,057
Maturities of marketable securities 22,598 131,008
Purchases of property and equipment (19,942) (7,785)
Purchase of other investment (4,000) 0
Proceeds from sale of equity investment 0 12,382
Net cash provided by (used in) investing activities (20,802) 151,299
Financing Activities    
Payments on debt 0 (45,000)
Payment of taxes withheld for vested stock awards (14,907) (16,078)
Proceeds from the issuance of common stock 8,147 9,396
Net cash used in financing activities (6,760) (51,682)
Increase in cash and cash equivalents 59,796 75,578
Cash and cash equivalents at beginning of period 281,607 227,504
Cash and cash equivalents at end of period $ 341,403 $ 303,082